Bowel Obstruction in Patients with Alpers-Huttenlocher Syndrome

Abstract

Alpers-Huttenlocher syndrome (AHS) is a very rare autosomal recessive disorder. AHS is caused by homozygous or compound heterozygous mutations in the nuclear gene encoding mitochondrial DNA polymerase gamma (POLG, chromosome 15q25). Most patients become symptomatic before the age of 2 years. We report 3 patients who were treated in our clinic between 2007 and 2010. All patients suffered from myoclonic seizures and had at least one refractory convulsive status which led to the diagnosis. All of them had varying degrees of developmental delay, 2 of them additionally ataxia. Gastrointestinal motility problems were severe in all patients despite only mildly deranged liver function. While in most aspects our patients present with typical AHS features, they also share intestinal problems, a feature that has not been recognized as typical for AHS before. AHS is a multisystem disorder that does affect all cell systems. Liver and brain are organs with the highest energy demand and are therefore usually affected early in the disease course of AHS. However, constipation and bowel obstruction should be regarded as typical complications in AHS and patients should be monitored and treated to improve quality of life. Regarding treatment options for epilepsy in AHS ketogenic diet as well as lacosamide might be considered.

Key words

Alpers-Huttenlocher syndrome (AHS) - constipation - gastrointestinal dysmotility - urinary retention - ketogenic diet - lacosamide - refractory convulsive status - EEG - MRI

• References

• 1 Amiot A, Tchikviladze M, Joly F et al. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology 2009; 137: 101-109
• 2 Cardena JF, Amato RS. Compound heterozygous gamma gene mutation in a patient with Alpers disease. Sem Pediatr Neurol 2010; 17: 62-64
• 3 Chang TM, Chi CS, Tsai CR et al. Paralytic ileus in MELAS with phenotypic features of MNGIE. Pediatr Neurol 2004; 31: 374-377
• 4 Cohen BH, Chinnery PF, Copeland WC. POLG-Related Disorders. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds.). Source GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle 1993; 2010 Mar 16
• 5 Davidzon G, Mancuso M, Ferraris S et al. POLG mutations and Alpers syndrome. Ann Neurol 2005; 57: 921-923
• 6 Filosto M, Mancuso M, Nishigaki Y et al. Clinical and genetic heterogeneity in progressive external opthalmoplegia due to mutations in polymerase gamma. Arch Neurol 2003; Sep 60 (9): 1279-1284
• 7 Giordano C, Sebastiani M, De Giorgio R et al. Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion. Am J Pathol 2008; 173: 1120-1128
• 8 Horváth R, Bender A, Abicht A et al. Heteroplasmic mutation in the anticodon-stem of mitochondrial tRNA(Val) causing MNGIE-like gastrointestinal dysmotility and cachexia. J Neurol 2009; 256: 810-815
• 9 Joshi CN, Greenberg CR, Mhanni AA et al. Ketogentic diet in Alpers-Huttenlocher syndrome. Pediatr Neurol 2009; 40: 314-316
• 10 Kapur RP, Fligner C, Maghsoodi B et al. Gastrointestinal neuromuscular pathology in Alpers disease. Am J Surg Pathol 2011; 35: 714-722
• 11 Kurt B, Jaeken J, Van Hove J et al. A novel POLG gene mutation in 4 children with Alpers-like hepatocerebral syndromes. Arch Neurol 2010; 67: 239-244
• 12 Sergeant GP, Bradley E, Thornbury KD et al. Role of mitochondria in modulation of spontaneous Ca²⁺ waves in freshly dispersed interstitial cells of Cajal from the rabbit urethra. J Physiol 2008; 586 (Pt 19) 4631-4642
• 13 Van Goethem G, Dermaut B, Löfgren A et al. Mutation of POLG is associated with progressive external opthalmoplegia characterized by mtDNA deletions. Nat Genet 2001; 28: 211-212
• 14 Zimmer V, Feiden W, Becker G et al. Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy. Neurogastroenterol Motil 2009; 21: 627-631